Zhejiang Huakang Pharmaceutical Past Earnings Performance
Past criteria checks 1/6
Zhejiang Huakang Pharmaceutical has been growing earnings at an average annual rate of 9.3%, while the Food industry saw earnings growing at 2.9% annually. Revenues have been growing at an average rate of 27.3% per year. Zhejiang Huakang Pharmaceutical's return on equity is 11.4%, and it has net margins of 13.1%.
Key information
9.3%
Earnings growth rate
0.08%
EPS growth rate
| Food Industry Growth | 7.2% |
| Revenue growth rate | 27.3% |
| Return on equity | 11.4% |
| Net Margin | 13.1% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses BreakdownBeta
How Zhejiang Huakang Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,767 | 361 | 137 | 136 |
| 31 Dec 23 | 2,783 | 371 | 128 | 124 |
| 30 Sep 23 | 2,654 | 339 | 113 | 124 |
| 30 Jun 23 | 2,619 | 363 | 122 | 105 |
| 31 Mar 23 | 2,445 | 359 | 120 | 97 |
| 31 Dec 22 | 2,200 | 319 | 114 | 100 |
| 30 Sep 22 | 1,994 | 308 | 108 | 96 |
| 30 Jun 22 | 1,813 | 263 | 94 | 105 |
| 31 Mar 22 | 1,671 | 236 | 88 | 90 |
| 31 Dec 21 | 1,594 | 237 | 87 | 84 |
| 30 Sep 21 | 1,519 | 257 | 89 | 85 |
| 30 Jun 21 | 1,344 | 237 | 80 | 73 |
| 31 Mar 21 | 1,311 | 253 | 74 | 73 |
| 31 Dec 20 | 1,320 | 307 | 67 | 65 |
| 30 Sep 20 | 1,350 | 297 | 203 | 94 |
| 31 Dec 19 | 1,511 | 270 | 161 | 54 |
| 31 Dec 18 | 1,400 | 199 | 126 | 44 |
| 31 Dec 17 | 925 | 56 | 112 | 28 |
| 31 Dec 16 | 763 | 29 | 89 | 22 |
Quality Earnings: 605077 has a high level of non-cash earnings.
Growing Profit Margin: 605077's current net profit margins (13.1%) are lower than last year (14.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 605077's earnings have grown by 9.3% per year over the past 5 years.
Accelerating Growth: 605077's earnings growth over the past year (0.7%) is below its 5-year average (9.3% per year).
Earnings vs Industry: 605077 earnings growth over the past year (0.7%) did not outperform the Food industry 1.1%.
Return on Equity
High ROE: 605077's Return on Equity (11.4%) is considered low.